Learn / RARE
NASDAQ: RARE
Ultragenyx Pharmaceutical (RARE) stock, explained like you're 5
Ultragenyx Pharmaceutical trades on the Nasdaq under the ticker RARE. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.5 billion dollars.
- Ticker
- RARE
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 1.5 billion dollars
Is Ultragenyx Pharmaceutical a small, medium or large cap company?
No. Ultragenyx Pharmaceutical is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.5 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Ultragenyx Pharmaceutical makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves RARE stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- MP Materials vs. USA Rare Earth: Which Rare Earth Stock Is the Better Buy? (Yahoo Finance)
- Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock Moved Up to "Hold" by UBS Group (MarketBeat)
- Indonesia faces rare MSCI exclusion that could cut it off from global capital (Reuters)
- For the Second Time in History, the Stock Market Sends a Rare Warning Signal and Points to Looming Trouble Ahead (The Motley Fool)
- Is Ultragenyx Pharmaceutical (RARE) Below Fair Value Following Its $203 Million Voucher Sale? (Simply Wall Street)
Follow RARE in your daily brief
Each trading day at 5 PM ET we post what happened to Ultragenyx Pharmaceutical and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow RARE
Questions about Ultragenyx Pharmaceutical stock
What does Ultragenyx Pharmaceutical do?
Ultragenyx Pharmaceutical trades on the Nasdaq under the ticker RARE. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.5 billion dollars.
What is the ticker symbol for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical trades under the ticker RARE on the Nasdaq.
What is Ultragenyx Pharmaceutical's market cap?
Ultragenyx Pharmaceutical is a small cap stock with a market cap of about 1.5 billion dollars.
How does Ultragenyx Pharmaceutical make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves RARE stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow RARE stock every day?
Add RARE to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.